These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 35032444)
21. Is carbamazepine a human teratogen? Vajda FJE; O'Brien TJ; Graham J; Lander CM; Eadie MJ J Clin Neurosci; 2016 Jan; 23():34-37. PubMed ID: 26521756 [TBL] [Abstract][Full Text] [Related]
22. Trends in harmful drug exposure during pregnancy in France between 2013 and 2019: A nationwide cohort study. Louchet M; Collier M; Beeker N; Mandelbrot L; Sibiude J; Chouchana L; Treluyer JM PLoS One; 2024; 19(1):e0295897. PubMed ID: 38198446 [TBL] [Abstract][Full Text] [Related]
23. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F; Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205 [TBL] [Abstract][Full Text] [Related]
24. [Possible exploitation of a pharmacovigilance center concerning the risk of teratogenesis]. Guilhem D; Castex V; Soubrié C Therapie; 1993; 48(1):47-9. PubMed ID: 8356545 [TBL] [Abstract][Full Text] [Related]
25. A new perspective on isotretinoin in pregnancy: Pregnancy outcomes, evaluation of complex phenotypes, and importance of teratological counselling. Alay MT; Kalayci A; Seven M Eur J Obstet Gynecol Reprod Biol; 2023 Dec; 291():148-155. PubMed ID: 37890418 [TBL] [Abstract][Full Text] [Related]
26. An update on teratogens for pediatric healthcare providers. Valladares DA; Rasmussen SA Curr Opin Pediatr; 2022 Dec; 34(6):565-571. PubMed ID: 36081369 [TBL] [Abstract][Full Text] [Related]
27. We don't know what we don't study: the case for research on medication effects in pregnancy. Parisi MA; Spong CY; Zajicek A; Guttmacher AE Am J Med Genet C Semin Med Genet; 2011 Aug; 157C(3):247-50. PubMed ID: 21766436 [TBL] [Abstract][Full Text] [Related]
28. Contraceptive Provision to Adolescent Females Prescribed Teratogenic Medications. Stancil SL; Miller M; Briggs H; Lynch D; Goggin K; Kearns G Pediatrics; 2016 Jan; 137(1):. PubMed ID: 26676050 [TBL] [Abstract][Full Text] [Related]
29. The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures. Charlton RA; Bettoli V; Bos HJ; Engeland A; Garne E; Gini R; Hansen AV; de Jong-van den Berg LTW; Jordan S; Klungsøyr K; Neville AJ; Pierini A; Puccini A; Sinclair M; Thayer D; Dolk H Eur J Clin Pharmacol; 2018 Apr; 74(4):513-520. PubMed ID: 29230493 [TBL] [Abstract][Full Text] [Related]
30. Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation. Cassina M; Cagnoli GA; Zuccarello D; Di Gianantonio E; Clementi M Eur J Med Genet; 2017 Jan; 60(1):22-31. PubMed ID: 27639441 [TBL] [Abstract][Full Text] [Related]
31. Counselling pregnant women at the crossroads of Europe and Asia: effect of Teratology Information Service in Turkey. Kaplan YC; Karadaş B; Küçüksolak G; Ediz B; Demir Ö; Sozmen K; Nordeng H Int J Clin Pharm; 2017 Aug; 39(4):783-790. PubMed ID: 28626851 [TBL] [Abstract][Full Text] [Related]
32. Prescription medicines with potential for foetal harm: dispensing before and during pregnancy in New Zealand, 2005-2015. Donald S; Sharples K; Barson D; Horsburgh S; Parkin L Eur J Clin Pharmacol; 2020 Jun; 76(6):887-896. PubMed ID: 32248249 [TBL] [Abstract][Full Text] [Related]
33. Pregnancy outcome following maternal exposure to statins: a multicentre prospective study. Winterfeld U; Allignol A; Panchaud A; Rothuizen LE; Merlob P; Cuppers-Maarschalkerweerd B; Vial T; Stephens S; Clementi M; De Santis M; Pistelli A; Berlin M; Eleftheriou G; Maňáková E; Buclin T BJOG; 2013 Mar; 120(4):463-71. PubMed ID: 23194157 [TBL] [Abstract][Full Text] [Related]
34. Editorial In Bed with The Devil: Recognizing Human Teratogenic Exposures. Friedman JM Birth Defects Res; 2017 Nov; 109(18):1407-1413. PubMed ID: 29152923 [No Abstract] [Full Text] [Related]
35. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Loureiro KD; Kao KK; Jones KL; Alvarado S; Chavez C; Dick L; Felix R; Johnson D; Chambers CD Am J Med Genet A; 2005 Jul; 136(2):117-21. PubMed ID: 15940677 [TBL] [Abstract][Full Text] [Related]
37. Teratogenicity of recently introduced medications in human pregnancy. Lo WY; Friedman JM Obstet Gynecol; 2002 Sep; 100(3):465-73. PubMed ID: 12220765 [TBL] [Abstract][Full Text] [Related]
38. Prenatal exposure to mycophenolate mofetil: an updated estimate. Klieger-Grossmann C; Chitayat D; Lavign S; Kao K; Garcia-Bournissen F; Quinn D; Luo V; Sermer M; Riordan S; Laskin C; Matok I; Gorodischer R; Chambers C; Levi A; Koren G J Obstet Gynaecol Can; 2010 Aug; 32(8):794-7. PubMed ID: 21050513 [TBL] [Abstract][Full Text] [Related]
39. Identification of misclassified pregnancy episodes in women of childbearing potential exposed to drugs with known teratogenic potential in the CPRD GOLD Pregnancy Register. Lee C; Rizzi S; Bierrenbach AL; Antunes L; Nissinen NM; Rocha O; Campbell J; Minassian C; Hodgson S; Broe A Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5761. PubMed ID: 38362650 [No Abstract] [Full Text] [Related]
40. Principles of human teratology: drug, chemical, and infectious exposure. Wilson RD; ; J Obstet Gynaecol Can; 2007 Nov; 29(11):911-917. PubMed ID: 17977495 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]